AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Morphoceuticals announced it raised $9.82 Million in an initial filing from an offering of $9.82 Million

Jan 23, 2023•over 2 years ago

Amount Raised

$9.82 Million

MedfordBiotechnology

Company Information

Company

Morphoceuticals

Location

Medford, Massachusetts, United States

About

Morphoceuticals is a new biotech company creating the first map of the druggable bioelectrome. By using multi-omics, bioelectric profiling and AI, we aim to exploit the electrical network controlling tissue repair and organ regeneration that exists throughout our bodies.

Company News

(5 articles)

Thu, 18 Apr 2024 07:00:00 GMT

Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology - Business Wire

Wed, 15 Feb 2023 08:00:00 GMT

Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine - PR Newswire

Tue, 22 Jul 2025 07:00:00 GMT

Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors - GlobeNewswire

Fri, 28 Jan 2022 08:00:00 GMT

Novel drug combination triggers successful limb regeneration in adult frogs - Longevity.Technology

Thu, 03 Oct 2024 07:00:00 GMT

To Reverse Aging’s Clock, Adjust the Cell’s Machinery - Genetic Engineering and Biotechnology News

FundzWatch™ Score

36

Medium Activity

4 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Sign in to view contact details

Sign in to view contact details